PRUEBA DE DIAGNÓSTICO IN VITRO PARA LA DETECCIÓN DE LA RESISTENCIA A LA RIFAMPICINA Y A LA ISONIAZID
Mexico·Clase II·III. Agentes de
diagnóstico·PRODUCTOS ROCHE, S.A.
DE C.V.·Registered June 07, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- COBAS® MTB –RIF / INH ROCHE.
- Trade Name (English)
- COBAS® MTB –RIF / INH ROCHE.
- Analysis ID
- 1662R2024 SSA
- Registration Date
- June 07, 2024
- Name (Spanish)
- PRODUCTOS ROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOS ROCHE, S.A. DE C.V.
Access comprehensive regulatory information for PRUEBA DE DIAGNÓSTICO IN VITRO PARA LA DETECCIÓN DE LA RESISTENCIA A LA RIFAMPICINA Y A LA ISONIAZID (PRUEBA DE DIAGNÓSTICO IN VITRO PARA LA DETECCIÓN DE LA RESISTENCIA A LA RIFAMPICINA Y A LA ISONIAZID) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1662R2024 SSA and manufactured by PRODUCTOS ROCHE, S.A. DE C.V.. The device was registered on June 07, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.